Legend: Palais des congrès de Montréal = CC, Le Westin Montréal = W, Intercontinental Montréal = I
A * preceding a session name means that the session is an applied session.
A ! preceding a session name means that the session reflects the JSM meeting theme.
A * preceding a session name means that the session is an applied session.
A ! preceding a session name means that the session reflects the JSM meeting theme.
Activity Details
|
|
Tweet | ||
| 673 * | Thu, 8/8/2013, 10:30 AM - 12:20 PM | CC-514c | |
| Bioequivalence (BE), History, and Developing Ideas — Topic Contributed Papers | |||
| Biopharmaceutical Section | |||
| Organizer(s): Lihui Zhao, Novartis Oncology | |||
| Chair(s): Lihui Zhao, Novartis Oncology | |||
| 10:35 AM | Bioequivalence Criteria Applied to Dose Proportionality — Brian Smith, Amgen, Inc. | ||
| 10:55 AM | Reference-Scaled Average Bioequivalence (SABE) — L. Endrenyi, Univ of Toronto ; Laszlo Tothfalusi, Semmelweis University | ||
| 11:15 AM | Multiplicity in Bioequivalence Trials: Multiple Formulation and Multiple Stage Designs — Lihui Zhao, Novartis Oncology ; Cheng Zheng, Novartis Oncology ; Jixian (Jason) Wang, Novartis Oncology | ||
| 11:35 AM | Discussant: Byron Jones, Novartis Pharma AG | ||
| 11:55 AM | Floor Discussion | ||
2013 JSM Online Program Home
For information, contact jsm@amstat.org or phone (888) 231-3473.
If you have questions about the Continuing Education program, please contact the Education Department.
The views expressed here are those of the individual authors and not necessarily those of the JSM sponsors, their officers, or their staff.
Copyright © American Statistical Association.